ArticleThe Lancet. Oncology2022

Chronic convection-enhanced delivery of topotecan for patients with recurrent glioblastoma: a first-in-patient, single-centre, single-arm, phase 1b trial.

Eleonora F Spinazzi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.